Cargando…
Serum LPS and CD163 Biomarkers Confirming the Role of Gut Dysbiosis in Overweight Patients with NASH
BACKGROUND: Gut-microbiota alterations and bacterial translocation might attribute to hepatic inflammation. Lipopolysaccharide stimulates toll-like receptor 4 leading to the activation of Kupffer cells which express the surface receptor, CD 163. OBJECTIVE: To assess the levels of CD 163 and LPS in o...
Autores principales: | Hegazy, Mona A, Mogawer, Sherif M, Alnaggar, Alshaimaa Rezk L R, Ghoniem, Olfat A, Abdel Samie, Rasha M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585799/ https://www.ncbi.nlm.nih.gov/pubmed/33116732 http://dx.doi.org/10.2147/DMSO.S249949 |
Ejemplares similares
-
Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH
por: Kang, Gideon G., et al.
Publicado: (2022) -
Modeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of Erysipelotrichales
por: Carter, James K., et al.
Publicado: (2021) -
Mac-2 binding protein in non-alcoholic fatty liver disease: Is it a reliable diagnostic biomarker? A pilot study
por: El-Aziz, Rokaya Abd, et al.
Publicado: (2020) -
Current Research on the Pathogenesis of NAFLD/NASH and the Gut–Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome
por: Kobayashi, Takashi, et al.
Publicado: (2022) -
Novel Application of the Traditional Lipid Ratios as Strong Risk Predictors of NASH
por: Hegazy, Mona, et al.
Publicado: (2020)